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Follicular lymphomas occur rarely in the gastrointestinal tract, representing only 1–3% of all gastrointestinal tract B-cell non-
Hodgkin lymphomas. We describe endoscopic analysis of 3 cases of follicular lymphoma in the small intestine using double-
balloon endoscopy. Double-balloon endoscopy revealed multiple nodular lesions and elevated white patches, multiple polypoid
lesions,andscatteredwhitepolypoidandnodularlesionsintheduodenumandsmallintestine.FujiIntelligentChromoEndoscopy
demonstrated small, whitish nodules, and narrow-band imaging showed a coiled, elongated vascular pattern within the elevated
lesions.Thesecasesaretheﬁrstfollicularlymphomasinthesmallintestineevaluatedusingnarrow-bandimagingorFujiIntelligent
Chromo Endoscopy to be reported.
Copyright © 2009 Manzurul Chowdhury et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
High-grade lymphomas are the most common histological
subtype of lymphoma in the gastrointestinal tract, with the
exception of the stomach, where low-grade lymphomas are
more common [1–3]. Gastrointestinal lymphomas predom-
inantly have a B-cell phenotype, whereas T-cell lymphomas
are rare and usually arise in the small intestine [1]. Mucosa-
associated lymphoid tissue (MALT) lymphomas are the most
frequent type of low-grade non-Hodgkin lymphoma (NHL)
encountered in the gastrointestinal tract. MALT lymphomas
account for 40% of all primary gastric lymphomas, while
multiple lymphomatous polyposis represents less than 10%
of primary gastrointestinal lymphomas [4, 5].
Follicular lymphomas (FLs) represent a distinct type of
low-grade NHLs characterized by neoplastic proliferation
of germinal center B cells arranged in round aggregates
that recapitulate the non-neoplastic germinal center. FL
accounts for up to 22% of all NHLs, and up to 70% of
all indolent NHLs [6–8]. Primary extranodal FL without
peripheral lymphadenopathy is very uncommon. FL rarely
occurs in the gastrointestinal tract, representing only 1–3%
of all gastrointestinal tract B-cell NHLs [9–14]. Herein we
report the endoscopic characterization of 3 cases of FL in the
small intestine using double-balloon endoscopy.
2.CaseReports
Case 1 was a 57-year-old male with a recent history of mild
abdominal discomfort. Upper gastrointestinal endoscopy
revealed white elevated nodules in the second part of the
duodenum (Figure 1(a)). Biopsy specimens demonstrated
FL that was positive for CD10 and BCL-2 and negative
for CD5 and cyclin D1 on immunohistochemical staining.
Double-balloon endoscopy showed multiple nodular lesions2 Gastroenterology Research and Practice
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Figure 1: (a) Endoscopic view of the duodenum. Upper GI endoscopy revealed elevated white nodules in the second part of the duodenum.
(b)Double-balloonendoscopicviewofthejejunum.Double-balloonendoscopyshowedmultiplenodularlesionsandelevatedwhitepatches
in the jejunum. (c) FICE view of the jejunum. FICE showed whitish small nodules in the jejunum.
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Figure 2: (a) Endoscopic view of the duodenum. Upper GI endoscopy showed multiple polypoid lesions in the duodenum. (b) NBI view
of the duodenum. NBI demonstrated a coiled, elongated vascular pattern within elevated lesions of the duodenum. (c) Double-balloon
endoscopic view of the jejunum. Double-balloon endoscopy showed multiple polypoid lesions in the jejunum.
andelevatedwhitepatchesfromthejejunumuptothetermi-
nal ileum, with the majority of lesions concentrated around
the proximal part of the ileum (Figure 1(b)). Fuji Intelligent
ChromoEndoscopy(FICE)(EG590-ZW,FujinonToshibaES
Systems, Tokyo, Japan) revealed small, whitish nodules in
the jejunum (Figure 1(c)). A computed tomography (CT)
scan of the chest and abdomen showed involvement of para-
aortic lymph nodes; thus, he was classiﬁed as having Stage
II2 disease according to the criteria of the International
Workshop in Lugano [15]. Although he was considered for
chemotherapy, he died due to an unknown cause before
treatment was initiated.
Case 2 was a 66-year-old male who was found to have
multiple polypoid lesions in the duodenum on routine
surveillance endoscopy (Figure 2(a)). Narrow-band imaging
(NBI) (H260Z, Olympus, Tokyo, Japan) demonstrated a
coiled, elongated vascular pattern within elevated lesions
of the duodenum (Figure 2(b)). Biopsy specimens revealed
FL that was immunohistochemically positive for CD10 and
BCL-2 and negative for CD5 and cyclin D1. Subsequent
double-balloonendoscopyshowedmultiplepolypoidlesions
involving the second and third parts of the duodenum and
the proximal part of the jejunum (Figure 2(c)). A CT scan
of the chest and abdomen did not show an involvement
of other structures or lymph nodes. Thus, the case was
staged as Stage I according to the Lugano classiﬁcation. As
the patient was asymptomatic, he is currently undergoing
regular observation.
Case 3 is a 48-year-old asymptomatic male in whom
a few scattered white polypoid lesions and a few isolated
nodular lesions in the duodenum were identiﬁed during
routine annual surveillance (Figure 3(a)). NBI demonstrated
a mildly elongated vascular pattern within elevated lesions
(Figure 3(b)). Biopsy specimens demonstrated the presence
of FL, which immunohistochemical analysis revealed to be
positive for CD10 and BCL-2 and negative for CD5 and
cyclin D1. Subsequent double-balloon endoscopy showed
scattered white polypoid and nodular lesions in the third
part of the duodenum and the proximal part of the jejunum
that were similar to the lesions observed in the second part
of the duodenum (Figure 3(c)). A CT scan of the chest
and abdomen showed a lack of other organ involvement.
Thus, this case was also staged as Stage I according to the
Lugano classiﬁcation. He is currently undergoing regular
observation.Gastroenterology Research and Practice 3
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Figure 3: (a) Endoscopic view of the duodenum. Upper GI endoscopy showed a few scattered white polypoid lesions and a few isolated
nodular lesions in the duodenum. (b) NBI view of the duodenum. NBI demonstrated a mildly elongated vascular pattern within elevated
lesions of the duodenum. (c) Double-balloon endoscopic view of the jejunum. Double-balloon endoscopy showed scattered white polypoid
and nodular lesion in the jejunum.
3. Discussion
Double-balloon endoscopic analysis of early-stage disease
has previously revealed multiple granules with a white color
and rough surface in the duodenum and jejunum; mul-
tiple polypoid lesions resembling lymphomatous polyposis
in the duodenum, jejunum, ileum, and rectum [16–18];
apparent lymphoid hyperplasia in the jejunum [19]. Capsule
endoscopy of early-stage FL revealed patchy, whitish nodules
with thickened mucosal folds in the proximal and middle
parts of the small intestine [20], nodular lesions in the
jejunumandileum[21],andpolypoidlesionsinthejejunum
[19].Theendoscopicappearancemayvaryfromﬂat,elevated
lesions to white, polypoid lesions, or a mixture of the two
types. The polypoid lesions of FL may resemble lymphoma-
tous polyposis or MALT lymphoma, both of which are
associated with a poor prognosis [22]. Thus, there is a need
to establish immunotyping and molecular biology assays
to enable appropriate diagnosis, prognostic determination,
evaluating prognosis, and treatment selection. Interestingly,
an increased incidence of FL in the duodenum has been
recently observed [10]. In the present analysis, 3 cases had
lesions in the duodenum and jejunum, and 2 cases had
lesions in the ileum.
Magniﬁed endoscopy images of gastrointestinal FL
have previously shown whitish granules corresponding to
enlarged villi [16]. NBI is a novel endoscopic technique that
can enhance the accuracy of diagnosis by using narrow-
bandwidth ﬁlters in a red-green-blue sequential illumination
system [23]. FICE simulates chromoendoscopy and can be
used to evaluate microstructure and blood capillaries of the
mucosal membrane [24]. The characterization of FL in the
small intestine using the magniﬁed endoscopy was clariﬁed
as a coiled or elongated vascular pattern within elevated
lesions by NBI, and small or whitish nodules by FICE in our
cases. Then, this is the ﬁrst report to characterize FL in the
small intestine by NBI or FICE.
Phenotypically, FL is characterized by expression of the
pan B-cell antigens CD19, CD20, and CD22, while surface
immunoglobulins, CD10, CD5, CD43, and nuclear cyclin
D1 expression are generally not expressed. These features
distinguish FL from MCL [12, 25–30]. In up to 85% of
cases, the neoplastic B cells in FL diﬀer from normal
germinalcenterBcellsinthattheycontaincytoplasmicBCL-
2p r o t e i n[ 31–33]. B-cell BCL-2 protein expression is useful
in discriminating FL from ﬂorid follicular hyperplasia, in
which BCL-2 is not expressed.
Transformation of FL into diﬀuse, high-grade NHLs is
relatively common and is associated with a poor prognosis
[34], and the frequency of histological transformation is
approximately 30% [35, 36]. The tendency of FL to trans-
form into high-grade NHL highlights the importance of his-
tological examination of even small lesions in the duodenum




with a “watch and wait” strategy demonstrated no survival
advantage for early intervention, thereby supporting the
“Stanford philosophy” of expectant management unless
treatment is perceived to be indicated [37]. Conventional
treatment options for FL include surgery, chemotherapy,
and radiotherapy. Recently, rituximab in combination with
chemotherapy has been shown to result in high response
rates in FL patients [38].
In conclusion, we have reported 3 cases of FL in the small
intestine characterized by double-balloon endoscopy, which
was also used to evaluate the accuracy of diagnosis of small
intestine lesions. These cases are the ﬁrst gastrointestinal FL
c a s e se v a l u a t e db yN B Io rF I C Et ob er e p o r t e d .
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